Effect of Subhypnotic Doses of Dexmedetomidine on Antitumor Immunity in Mice
Authors:
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 27 (3) , 357-369
Abstract
Dexmedetomidine, a selective α2 adrenergic receptor agonist, is a drug often used for sedation. Despite the high prevalence of sedating patients with tumors in intensive care settings, little is known about the effect of sedative drugs on tumor growth. We studied the effect of dexmedetomidine on antitumor immunity in mice. Subhypnotic doses of dexmedetomidine decreased interleukin (IL)-12 production from thioglycollate-induced macrophages. The treatment also decreased the ratio of the helper T lymphocytes subsets, Th1 to Th2 (Th1/Th2), in the spleen. Following subcutaneous inoculation of EL4 T-cell lymphoma cells, dexmedetomidine further decreased the splenic Th1/Th2 ratio and activity of EL4-specific cytotoxic T lymphocytes (CTLs). Finally, treatment with dexmedetomidine accelerated EL4 growth in mice. These data show that treatment of mice with subhypnotic doses of dexmedetomidine downregulates antitumor immunity, possibly through the decreased production of IL-12 from antigen presenting cells, resulting in a Th2 shift and decreased CTL activity against EL4 in mice.Keywords
This publication has 20 references indexed in Scilit:
- Ligand-induced α2-adrenoceptor endocytosis: relationship to Gi protein activationBiochemical and Biophysical Research Communications, 2004
- The involvement of α2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in miceEuropean Journal of Pharmacology, 2004
- Activation of α2 Adrenergic Receptors Suppresses Fear Conditioning: Expression of c-Fos and Phosphorylated CREB in Mouse AmygdalaNeuropsychopharmacology, 2003
- Stimulation of interleukin-12 production in mouse macrophages via activation of p38 mitogen-activated protein kinase by α2-adrenoceptor agonistsEuropean Journal of Pharmacology, 2003
- Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjectsBiological Procedures Online, 2003
- The Role of the α2-Adrenoceptor Agonist Dexmedetomidine in Postsurgical Sedation in the Intensive Care UnitJournal of Intensive Care Medicine, 2003
- Resistance of Macrophages toMycobacterium aviumIs Induced by α2-Adrenergic StimulationInfection and Immunity, 2003
- Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-α production by α2- and β-adrenoceptors in miceJournal of Neuroimmunology, 2000
- Predominance of TH1 Response in Tumor-Bearing Mice and Cancer Patients Treated With AS 101JNCI: Journal of the National Cancer Institute, 1996
- Stress-induced immune suppression: Role of brain corticotropin releasing hormone and autonomic nervous system mechanismsAdvances in Neuroimmunology, 1994